Andreas Kronbichler
@AKronbichler
Loves nephrology! Mountain lover! Views my own.
ID:976078287050104832
20-03-2018 12:49:33
2,3K Tweets
2,1K Followers
795 Following
Great hospitality as always Andreas Kronbichler Annemarie Weißenbacher. Nice talks post ☕️☕️break from Mayo Clinic Nephrology colleagues @mayoclinic’s Alí Duarte, MD Hans-Joachim Anders Laurent ARNAUD and I. Bajesma.
Good morning #salzburg from the second Mayo Clinic #austrian #meeting Haemato-Oncology meets Nephrology and a #transplant surgeon 😁 Andreas Kronbichler Priya Alexander, MD Gregor Bond Clatworthy Lab Sandra Herrmann MD, FASN VisitSalzburgerland
This was such a wonderful opportunity to talk about long-term
renal prognosis of our patients with rare kidney diseases. And in the meantime recruiting a patient with a very rare kidney disease into a fantastic trial! Thank you Prof Danny Gale
Looking forward to seeing you here in Salzburg and of course we will have an amazing SLE sessions - with Laurent ARNAUD Alí Duarte, MD Ingeborg Bajema and Hans-Joachim Anders
Not only in the UK! Jen offers everything we want to have in a Council! ERA - European Renal Association She has been one of our most important young nephrologists and is a perfect speaker for the needs of YNP of ERA (etc.)
Tonight: Part 2 of our NDT Special on Ca Intake in CKD Pat with Prof. Marc Vervloet Pieter Evenepoel & Andreas Kronbichler
Academic Partners ÖGN - Österreichische Gesellschaft für Nephrologie Deutsche Gesellschaft für Nephrologie (DGfN) e.V. SFNDT
Part 1 has been streamed few days ago: youtu.be/TZYemLMKzPM?si…
youtu.be/aPOhCwR9aas?si… via YouTube
Don’t feel fatigued when watching this! A huge unmet need in nephrology! Thanks to L. Parker Gregg and others, research will hopefully help us to improve it!
Thank you Maine-Anjou AAV-GN Research Group for highlighting the article. The Appendix focuses on CKD and CVD management. Not enough space to discuss these fascinating diseases!
Great news Jochen Reiser MD PhD and Walden Biosciences! A P2 is certainly needed to understand the impact of anti-suPAR treatment on proteinuria in proteinuric kidney diseases